Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

N. Nora Bennani, Pamela Atherton, Kimberly O Steinert, Lisa M. Rimsza, Aung M. Tun, Marc S. Hoffmann, Mayur S. Narkhede, Rakhee Vaidya, Rabih Said, Geoffrey I Shapiro, Brian A Costello, Stephen M Ansell, Grzegorz S. Nowakowski

Blood (2023) 142 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2023-190540

Published: 2023

Journal Articles

A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

N. Nora Bennani, MD, Levi D Pederson, Pamela Atherton, Ivana Micallef, MD, Joseph P. Colgan, MD, Gita Thanarajasingam, MD, Grzegorz Nowakowski, MD, Thomas E. Witzig, MD, Andrew L. Feldman, MD, Stephen M Ansell, MD

Blood (2019) 134 (Supplement_1): 467.

https://doi.org/10.1182/blood-2019-126194

Published: 2019

Journal Articles

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

Aref Al-Kali, MD, Raoul Tibes, MD PhD, Jeanne Palmer, MD, Hassan B. Alkhateeb, MD, Mrinal M. Patnaik, MD MBBS, Kebede H. Begna, MD, Naseema Gangat, MBBS, Pamela Atherton, Shujun Liu, PhD, Rong He, MD, Shahrukh K. Hashmi, MD MPH, Mark R. Litzow, MD

Blood (2018) 132 (Supplement 1): 1443.

https://doi.org/10.1182/blood-2018-99-118552

Published: 2018

Journal Articles

A Phase II of Combination D aunorubicin and Cytarabine ( A ra-c) and Nilotinib ( TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

Aref Al-Kali, MD, Raoul Tibes, MD PhD, Jeanne Palmer, MD, Hassan B Alkhateeb, MD, Pamela Atherton, Fei Yan, Shujun Liu, PhD, Rong He, MD, Shahrukh K. Hashmi, MD, Mark R Litzow, MD

Blood (2015) 126 (23): 3808.

https://doi.org/10.1182/blood.V126.23.3808.3808

Published: 2015

Journal Articles

The Burden of Fatigue and Quality of Life in Myeloproliferative Disorders (MPDs): An International Internet Based Survey of 1179 MPD Patients.

Ruben A. Mesa, MD, Joyce Niblack, JD, Martha Wadleigh, MD, D.G. Gilliland, MD, Srdan Verstovsek, MD, Hagop Kantarjian, MD, John Camoriano, MD, Lawrence Solberg, MD, Sunni Barnes, PhD, Angelina Tan, Pamela Atherton, Jeffrey Sloan, PhD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 4872.

https://doi.org/10.1182/blood.V108.11.4872.4872

Published: 2006

Journal Articles

Phenotypic Differences amongst Subgroups of Patients with Myelofibrosis with Myeloid Metaplasia (MMM): Analysis of 458 MMM Patients.

Ruben Mesa, MD, Joyce Niblack, JD, Srdan Verstovsek, MD, Sunni Barnes, PhD, Angelina Tan, Pamela Atherton, Jeffrey Sloan, PhD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 4878.

https://doi.org/10.1182/blood.V108.11.4878.4878

Published: 2006

NARROW

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

A Phase II of Combination D aunorubicin and Cytarabine ( A ra-c) and Nilotinib ( TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

The Burden of Fatigue and Quality of Life in Myeloproliferative Disorders (MPDs): An International Internet Based Survey of 1179 MPD Patients.

Phenotypic Differences amongst Subgroups of Patients with Myelofibrosis with Myeloid Metaplasia (MMM): Analysis of 458 MMM Patients.

Email alerts

ASH Publications

American Society of Hematology

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

A Phase II of Combination D aunorubicin and Cytarabine ( A ra-c) and Nilotinib ( TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

The Burden of Fatigue and Quality of Life in Myeloproliferative Disorders (MPDs): An International Internet Based Survey of 1179 MPD Patients.

Phenotypic Differences amongst Subgroups of Patients with Myelofibrosis with Myeloid Metaplasia (MMM): Analysis of 458 MMM Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only